A Single-center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment - A Phase IIa Study

Trial Profile

A Single-center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment - A Phase IIa Study

Suspended
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2018

At a glance

  • Drugs Oshadi D (Primary) ; Oshadi R (Primary)
  • Indications Mesothelioma
  • Focus Adverse reactions
  • Sponsors Oshadi Drug Administration
  • Most Recent Events

    • 16 Apr 2018 Status changed from not yet recruiting to suspended.
    • 28 Mar 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018, according to ClinicalTrials.gov record.
    • 28 Mar 2016 Planned initiation date changed from 1 Jul 2014 to 1 Dec 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top